SubHero Banner

Sevenfact® (coagulation factor VIIa [recombinant]-jncw) – New drug approval

April 1, 2020 - The FDA announced the approval of LFB S.A’s Sevenfact (coagulation factor VIIa [recombinant]-jncw), for the treatment and control of bleeding episodes occurring in adults and adolescents (12 years of age and older) with hemophilia A or B with inhibitors.

Download PDF